M&A Deal Summary

Venn Life Sciences Holding Acquires Innovenn UK

On October 4, 2016, Venn Life Sciences Holding acquired consumer products company Innovenn UK from Innovenn for 5M GBP

Acquisition Highlights
  • This is Venn Life Sciences Holding’s 1st transaction in the Consumer Products sector.
  • This is Venn Life Sciences Holding’s largest (disclosed) transaction.
  • This is Venn Life Sciences Holding’s 2nd transaction in the United Kingdom.

M&A Deal Summary

Date 2016-10-04
Target Innovenn UK
Sector Consumer Products
Buyer(s) Venn Life Sciences Holding
Sellers(s) Innovenn
Deal Type Divestiture
Deal Value 5M GBP

Target

Innovenn UK

Campus York, United Kingdom
Innovenn UK Ltd. engages in development and marketing of healthcare products and technologies for living skin model, and an anti-acne formulation.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Venn Life Sciences Holding

Dublin, Ireland

Category Company
Sector Healthcare Services
Revenue 56M EUR (2023)
DESCRIPTION

Venn Life Sciences Holding is an entity which provides a broad range of Clinical Trial Services through experienced and focused operations team and a network of skilled investigators and partners. Venn Life Sciences Holding is based in Dublin, Ireland.


DEAL STATS #
Overall 3 of 3
Sector (Consumer Products) 1 of 1
Type (Divestiture) 1 of 1
Country (United Kingdom) 2 of 2
Year (2016) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-05 Cardinal Systems SAS

Paris, France

Cardinal Systems, a France-based CRO specializing in data management and randomization systems.

Buy -

Seller(S) 1

SELLER

Innovenn

Dublin, Ireland

Category Company
Founded 2014
Sector Consumer Products
DESCRIPTION

Innovenn is an innovative skin science company with a unique portfolio of in vitro products and services. Innovenn are at the forefront of reconstructed in vitro skin technologies that are helping to enhance innovative skincare research and development. Company skin science division combines advanced living skin models, carefully designed in house testing services and research and development opportunities that offer a complete facilitation for the development of skin care products and their ingredients.


DEAL STATS #
Overall 1 of 1
Sector (Consumer Products) 1 of 1
Type (Divestiture) 1 of 1
Country (United Kingdom) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1